Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Dasatinib (Primary) ; Erlotinib (Primary) ; Everolimus (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Acronyms BIOMEDE
- 10 Jun 2017 Biomarkers information updated
- 18 Feb 2015 Planned number of patients changed from 225 to 250 as reported by ClinicalTrials.gov record.
- 24 Nov 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.